ADPT
Adaptive Biotechnologies Corp
NASDAQ: ADPT · HEALTHCARE · BIOTECHNOLOGY
$13.53
-3.63% today
Updated 2026-04-29
Market cap
$2.16B
P/E ratio
—
P/S ratio
7.80x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$8 – $21
Volume
1.9M
Adaptive Biotechnologies Corp (ADPT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38.45M | $55.66M | $85.07M | $98.38M | $154.34M | $185.31M | $170.28M | $178.96M | $276.98M |
| Revenue growth (YoY) | — | +44.8% | +52.8% | +15.6% | +56.9% | +20.1% | -8.1% | +5.1% | +54.8% |
| Cost of revenue | $15.68M | $19.67M | $22.27M | $22.53M | $49.30M | $57.91M | $75.55M | $72.08M | $71.36M |
| Gross profit | $22.77M | $35.99M | $62.80M | $75.85M | $105.04M | $127.40M | $94.72M | $106.88M | $205.62M |
| Gross margin | 59.2% | 64.7% | 73.8% | 77.1% | 68.1% | 68.7% | 55.6% | 59.7% | 74.2% |
| R&D | $32.00M | $39.16M | $70.70M | $116.07M | $142.34M | $141.76M | $122.12M | $102.95M | $93.77M |
| SG&A | $15.95M | $20.41M | $30.33M | $49.54M | $74.50M | $88.53M | $83.93M | $72.81M | $72.70M |
| Operating income | $-44.48M | $-49.76M | $-78.39M | $-152.82M | $-208.97M | $-200.19M | $-227.03M | $-162.55M | $-57.12M |
| Operating margin | -115.7% | -89.4% | -92.1% | -155.3% | -135.4% | -108.0% | -133.3% | -90.8% | -20.6% |
| EBITDA | $-37.84M | $-43.76M | $-70.60M | $-144.34M | $-193.34M | $-175.21M | $-189.27M | $-128.76M | $-29.85M |
| EBITDA margin | -98.4% | -78.6% | -83.0% | -146.7% | -125.3% | -94.6% | -111.2% | -71.9% | -10.8% |
| EBIT | $-43.63M | $-49.76M | $-78.39M | $-152.82M | $-207.30M | $-196.13M | $-211.50M | $-148.01M | $-47.68M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $1.67M | $4.24M | $13.80M | $11.58M | $11.78M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-42.83M | $-46.45M | $-68.61M | $-146.23M | $-207.28M | $-200.19M | $-225.25M | $-159.49M | $-59.50M |
| Net income growth (YoY) | — | -8.4% | -47.7% | -113.1% | -41.8% | +3.4% | -12.5% | +29.2% | +62.7% |
| Profit margin | -111.4% | -83.4% | -80.6% | -148.6% | -134.3% | -108.0% | -132.3% | -89.1% | -21.5% |